Your browser doesn't support javascript.
loading
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer.
Lindholm, Evita Maria; Ragle Aure, Miriam; Haugen, Mads Haugland; Kleivi Sahlberg, Kristine; Kristensen, Vessela N; Nebdal, Daniel; Børresen-Dale, Anne-Lise; Lingjaerde, Ole Christian; Engebraaten, Olav.
Afiliação
  • Lindholm EM; Department of Cancer Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Norway.
  • Ragle Aure M; Department of Cancer Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Norway.
  • Haugen MH; Department of Cancer Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Norway.
  • Kleivi Sahlberg K; Department of Tumor biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Norway.
  • Kristensen VN; Department of Cancer Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Norway.
  • Nebdal D; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway.
  • Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Norway.
  • Lingjaerde OC; Department of Clinical Molecular Biology (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, Norway.
  • Engebraaten O; Department of Cancer Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Norway.
Mol Oncol ; 13(10): 2278-2296, 2019 10.
Article em En | MEDLINE | ID: mdl-31402562
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Regulação Neoplásica da Expressão Gênica / MicroRNAs / Bevacizumab / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Noruega País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Regulação Neoplásica da Expressão Gênica / MicroRNAs / Bevacizumab / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Mol Oncol Assunto da revista: BIOLOGIA MOLECULAR / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Noruega País de publicação: Estados Unidos